Skip to main content

Table 2 Comparison of the mutation frequency of TP53 and KRAS in different literature

From: Pulmonary large cell carcinoma with neuroendocrine morphology shows genetic similarity to large cell neuroendocrine carcinoma

 

TP53

KRAS

Rekhtman et al. (LCC) [6]

–

5 / 20 (25%)

Pelosi et al. (LCC) [17]

12 / 20 (60%)

4 / 20 (20%)

Harms et al. (LCC) [3]

11 / 19 (58%)

6 / 19 (32%)

Liu et al. (LCC) [12]

4 / 8 (50%)

2 / 8 (25%)

Zhou et al. (LCC) [18]

3 / 5 (60%)

–

Our data (LCC)

4 / 7 (57.1%)

3 / 7 (42.8%)

Our data (LCNEC-null)

11 / 11 (100%)

0 / 11 (0%)

Our data (LCNEC)

12 / 13 (92.3%)

1 / 13 (7.7%)

Zhou et al. (LCNEC) [18]

12 / 14 (86%)

–

Karlsson et al. (LCNEC) [19]

28 / 32 (87.5%)

2 / 32 (6%)

Naidoo et al. (LCNEC) [11]

–

4 / 17 (24%)

Miyoshi et al. (LCNEC) [20]

55 / 78 (71%)

5 / 78 (6%)

George et al. (LCNEC) [21]

55 / 60 (92%)

6 / 60 (10%)

Rekhtman et al. (LCNEC) [22]

35 / 45 (78%)

10 / 45 (22%)